Skip to main content
TipRanks
Go Ultimate75% OFF

Critical Reagent Processing (CRPC) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Critical Reagent Processing has a market cap or net worth of CAD 842.58K. The enterprise value is CAD 383.11K.

Market Cap
CAD 842.58K
Enterprise Value
CAD 383.11K

Share Statistics

Critical Reagent Processing has 10,532,298 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
10,532,298
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Critical Reagent Processing’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
0
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Critical Reagent Processing had revenue of ― and earned -177.09K in profits. Earnings per share was ―.

Revenue
―
Gross Profit
―
Operating Income
-177.09K
Pretax Income
―
Net Income
-177.09K
EBITDA
-177.09K
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
-0.06
52-Week Price Change
6.67%
50-Day Moving Average
0.10
200-Day Moving Average
0.12
Relative Strength Index (RSI)
21.77
Average Volume (3m)
30.77K

Important Dates

Critical Reagent Processing upcoming earnings date is Nov 30, 2026, TBA (Not Confirmed).

Last Earnings Date
Oct 28, 2026
Next Earnings Date
Nov 30, 2026
Ex-Dividend Date
―

Balance Sheet

Critical Reagent Processing has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 0.00
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Critical Reagent Processing is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
-9.52%